JPWO2022158992A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022158992A5 JPWO2022158992A5 JP2023543464A JP2023543464A JPWO2022158992A5 JP WO2022158992 A5 JPWO2022158992 A5 JP WO2022158992A5 JP 2023543464 A JP2023543464 A JP 2023543464A JP 2023543464 A JP2023543464 A JP 2023543464A JP WO2022158992 A5 JPWO2022158992 A5 JP WO2022158992A5
- Authority
- JP
- Japan
- Prior art keywords
- score
- patient
- pharmaceutical combination
- kpps
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PT2021/050001 WO2022158991A1 (en) | 2021-01-20 | 2021-01-20 | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa |
| PTPCT/PT2021/050001 | 2021-01-20 | ||
| PCT/PT2021/050026 WO2022158992A1 (en) | 2021-01-20 | 2021-08-04 | Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024527175A JP2024527175A (ja) | 2024-07-22 |
| JPWO2022158992A5 true JPWO2022158992A5 (https=) | 2024-07-29 |
| JP2024527175A5 JP2024527175A5 (https=) | 2024-07-29 |
Family
ID=74494985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543464A Pending JP2024527175A (ja) | 2021-01-20 | 2021-08-04 | レボドパと組み合わせるオピカポンを用いたパーキンソン病に関連する疼痛の治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240066015A1 (https=) |
| EP (1) | EP4281071A1 (https=) |
| JP (1) | JP2024527175A (https=) |
| CN (1) | CN116963735A (https=) |
| WO (2) | WO2022158991A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3860603A1 (en) | 2018-10-05 | 2021-08-11 | Neurocrine Biosciences, Inc. | Methods for the administration of comt inhibitors |
| EP4360627A1 (fr) * | 2022-10-26 | 2024-05-01 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Traitement de l'arthrose par des inhibiteurs de comt |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20000635A0 (fi) * | 2000-03-17 | 2000-03-17 | Orion Yhtymae Oyj | COMT-inhibiittoreiden käyttö analgeettina |
| JP5435165B2 (ja) * | 2012-05-31 | 2014-03-05 | 小野薬品工業株式会社 | 医薬用途 |
| PT3782617T (pt) * | 2014-09-04 | 2024-02-29 | Lobsor Pharmaceuticals Ab | Composições farmacêuticas de gel compreendendo levodopa, carbidopa e entacapona |
| JP2018500300A (ja) * | 2014-11-28 | 2018-01-11 | ノヴィファーマ，エス．アー． | パーキンソン病を遅延させるための医薬 |
| MX383906B (es) * | 2015-10-09 | 2025-03-14 | Teva Pharmaceuticals Int Gmbh | Combinación de levodopa deuterado con carbidopa y opicapona para el tratamiento del mal de parkinson |
| JP2024500754A (ja) * | 2020-12-17 | 2024-01-10 | ビアル－ポルテラ エ コンパニア，ソシエダッド アノニマ | 早期特発性パーキンソン病のための治療レジメン |
-
2021
- 2021-01-20 WO PCT/PT2021/050001 patent/WO2022158991A1/en not_active Ceased
- 2021-08-04 JP JP2023543464A patent/JP2024527175A/ja active Pending
- 2021-08-04 WO PCT/PT2021/050026 patent/WO2022158992A1/en not_active Ceased
- 2021-08-04 CN CN202180095156.0A patent/CN116963735A/zh active Pending
- 2021-08-04 US US18/273,515 patent/US20240066015A1/en active Pending
- 2021-08-04 EP EP21752278.8A patent/EP4281071A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023109969A5 (https=) | ||
| JP2007514750A5 (https=) | ||
| ES2313330T3 (es) | Derivados de alfa-aminoamida utiles en el tratamiento del sindrome de piernas inquietas. | |
| CN101291663A (zh) | 预防和治疗睡眠呼吸障碍的方法和工具 | |
| Factor et al. | Emergency department presentations of patients with Parkinson's disease | |
| JP2006516571A5 (https=) | ||
| Kamel et al. | Magnesium sulphate within multimodal analgesia, pre-emptive, or preventive analgesia | |
| CY1111783T1 (el) | Θεραπεια συνδυασμου διαταραχων κατωτερης ουροποιητικης οδου με 2 προσδεματα και μη στεροειδες αντιφλεγμονωδες φαρμακο | |
| CN104258278A (zh) | 骨伤灵喷雾剂 | |
| Chaudhari et al. | Withania somnifera as an adjunctive treatment for refractory restless legs syndrome in Parkinson’s disease: A case report | |
| JPWO2022158992A5 (https=) | ||
| AU2002365036B2 (en) | Prevention of flap necrosis in plastic surgery | |
| CN102600343B (zh) | 治疗口腔疾病和/或牙痛中药制剂 | |
| CN115957257B (zh) | 一种治疗便秘的中药组合物、贴敷剂及其制备方法 | |
| US12005068B2 (en) | Formulation including doxycycline hyclate and method for administering the same | |
| JP4890250B2 (ja) | 火傷した皮膚を治療するための方法及び組成物 | |
| JPWO2022081033A5 (https=) | ||
| JP2014530249A5 (https=) | ||
| Yu et al. | Creatine derivatives: rapid complete relief of pain by topical or transcutaneous administration | |
| CN101040989A (zh) | 除燥润肤剂 | |
| Hatipoğlu et al. | Symptomatic Agents for Pediatric Ear, Nose, and Throat Infections | |
| Coric et al. | EFFECTS OF A MULTIMODAL THERAPY PROGRAM (MTP) INCLUDING RADONTHERMAL THERAPY (RTT) ON BASDAI SCORES AND PAIN IN INPATIENTS WITH ANKYLOSING SPONDYLITIS (AS) | |
| Horrigan | Aromatherapy in the management and treatment of rheumatoid and musculoskeletal autoimmune disorders: Part III | |
| RU2200561C1 (ru) | Способ лечения и профилактики заболеваний | |
| JPWO2022076818A5 (https=) |